CBIZ, Inc. 2024 Q2 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024. CBIZ, Inc. is a diversified professional services company operating through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company serves small and medium-sized businesses, individuals, governmental entities, and not-for-profits primarily in the U.S. and Canada.
Key Financial Metrics
| Metric | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenue | $420.0 million | $398.5 million | $914.3 million | $853.1 million |
| Net Income | $19.8 million | $26.9 million | $96.7 million | $100.0 million |
| Diluted EPS | $0.39 | $0.53 | $1.92 | $1.98 |
| Operating Income | $31.6 million | $38.7 million | $130.7 million | $136.7 million |
| Gross Margin | $53.6 million (12.8%) | $54.5 million (13.7%) | $171.5 million (18.8%) | $168.1 million (19.7%) |
| Cash from Operations (YTD) | $24.4 million | $29.7 million | $24.4 million | $29.7 million |
| Total Debt (Long-term) | $381.0 million | $312.4 million | $381.0 million | $312.4 million |
| Available Liquidity | $209.8 million | N/A | $209.8 million | N/A |
Note: Liquidity represents available funds under the 2022 credit facility net of letters of credit.
Material Changes vs. Prior Period
- Revenue Growth: Q2 revenue increased 5.4% year-over-year, driven by a 2.8% increase in same-unit revenue and 2.6% contribution from acquisitions. YTD revenue grew 7.2%.
- Profitability Decline: Net income decreased 26.3% in Q2 and 3.3% YTD. Operating income declined due to higher operating expenses and corporate G&A costs.
- Expense Increases: Corporate G&A expenses rose 39.6% in Q2 (29.8% YTD), primarily due to legal and professional fees associated with the pending Marcum transaction. Operating expenses increased 6.5% in Q2, driven by higher personnel costs ($18.1 million increase) and technology costs.
- Debt Levels: Bank debt increased from $312.4 million to $381.0 million, reflecting higher average debt balances and interest rates (weighted average 5.41% YTD 2024 vs. 4.94% YTD 2023).
- Segment Performance: Financial Services revenue grew 6.3% Q2; Benefits and Insurance Services grew 1.6%; National Practices grew 13.9%.
Guidance, Outlook, and Risks
Major Transaction: On July 30, 2024, CBIZ entered into a Merger Agreement to acquire the non-attest business of Marcum LLP for approximately $2.3 billion (cash and stock). The transaction is expected to close in Q4 2024, subject to regulatory and shareholder approvals. The company has secured a $2.0 billion senior secured credit facility commitment to fund the cash portion.
Capital Allocation: The company prioritizes strategic acquisitions. A share repurchase program was authorized for up to 5.0 million shares, expiring March 31, 2025. No open market repurchases were made in Q2 2024, though 0.2 million shares were repurchased for tax withholding purposes.
Risks and Contingencies:
- Transaction Risks: Failure to close the Marcum deal could result in termination fees (up to $48.0 million) and disrupt operations. Integration risks and increased leverage are significant concerns.
- Legal Proceedings: The company is a defendant in multidistrict litigation (MDL) regarding the May 2023 MOVEit cyberattack. The outcome and potential losses are currently indeterminable. A separate lawsuit regarding the sale of CBIZ MMP to Zotec Partners resulted in a $3.1 million award to CBIZ, which is under appeal.
- Deferred Compensation Plan: Volatility in the non-qualified deferred compensation plan impacts reported operating expenses and other income, though it has no impact on pre-tax income or EPS.
Investor Verification Checklist
- Transaction Closing Conditions: Verify progress on regulatory approvals (Hart-Scott-Rodino) and shareholder votes required for the Marcum acquisition.
- Financing Terms: Confirm the final terms and closing of the $2.0 billion senior secured credit facility committed for the Marcum deal.
- Cybersecurity Litigation: Monitor developments in the MOVEit MDL for potential liability estimates or settlement discussions.
- Margin Compression: Assess whether the increase in Corporate G&A expenses is temporary (transaction-related) or indicative of a structural cost increase.
- Debt Covenants: Review compliance with leverage and interest coverage ratios under the 2022 credit facility, especially given the increased debt load.